Trial intelligence / Profile preview

Freezed-dried Plasma in Trauma Patients with Coagulopathy

NCT02750150Phase 3Completed

Sponsor
CHU de Lille
Start
Jul 2013
Primary completion
Apr 2016
Modality
Biologic, Plasma product
Countries
1
01

Overview

Phase 3, randomised trial of dried plasma in coagulopathy (2 arms), sponsored by CHU de Lille. Primary endpoint: Fibrinogen concentration (Clauss) at 45 minutes. Started Jul 2013; status: completed.

02

Drugs

dried plasma
03

Conditions

coagulopathy

Beyond the preview

Go deeper on NCT02750150.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02750150.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call